Skip to main content

Nonprofit · EIN 26-2943602

SOCIETY OF UROLOGIC ONCOLOGY CLINICAL TRIALS CONSORTIUM

Tax-exempt · SCHAUMBURG, IL 60173

Financials

$332K$238K2022$554K$270K2023$685K$313K2024
Revenue Expenses · by fiscal year end
Financials of SOCIETY OF UROLOGIC ONCOLOGY CLINICAL TRIALS CONSORTIUM by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
April 30, 2025990$684,500$313,029$371,471$1,810,558$82,741$1,727,817
April 30, 2024990$553,700$270,281$283,419$1,404,532$48,186$1,356,346
April 30, 2023990$332,300$237,946$94,354$1,105,625$32,698$1,072,927
Financial details: 990 for the year ended April 30, 2025

Revenue

Contributions, gifts and grants
$0
Program service revenue
$684,500
Investment income
$0
Other revenue
$0

Expenses

Grants and similar amounts paid
$0
Compensation of officers, directors and key employees
$0
Salaries, compensation and benefits (total)
$0
Professional fundraising fees
$0
Travel
$3,957
Program services (functional)
$253,237
Management and general (functional)
$59,792

Balance sheet and other

Total assets, start of year
$1,404,532
Total assets, end of year
$1,810,558
Total liabilities, end of year
$82,741
Net assets, end of year
$1,727,817
Net assets without donor restrictions
$1,727,817
Gross receipts
$684,500
Employees
0
Volunteers
9
Year formed
2008
State of legal domicile
IL

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended April 30, 2025, highest compensation first.

NameTitleHours / weekCompensation
Viraj A Master MD PhD FACSPresident
Trustee or director, Officer
1$0
Brian Matthew Shuch MDTreasurer
Trustee or director, Officer
1$0
Gennady Bratslavsky MDPAST PRESIDENT
Trustee or director, Officer
1$0
Daniel W Lin MDDirector
Trustee or director
1$0
Adam Stuart Kibel MDDirector
Trustee or director
1$0
Kirsten Lynn Greene MD MSDirector
Trustee or director
1$0
Sam S Chang MD MBADirector
Trustee or director
1$0
W Marston Linehan MDDirector
Trustee or director
1$0
Padraic O'Malley MSc MDDirector
Trustee or director
1$0
Ms Pam MurphyExecutive Dir.
Officer
1$0
990 for the year ended April 30, 2024: 10 people
NameTitleHours / weekCompensation
Viraj A Master MD PhD FACSPresident
Trustee or director, Officer
1$0
Brian Matthew Shuch MDTreasurer
Trustee or director, Officer
1$0
Gennady Bratslavsky MDPAST PRESIDENT
Trustee or director, Officer
1$0
Daniel W Lin MDDirector
Trustee or director
1$0
Adam Stuart Kibel MDDirector
Trustee or director
1$0
Kirsten Lynn Greene MD MSDirector
Trustee or director
1$0
Sam S Chang MD MBADirector
Trustee or director
1$0
W Marston Linehan MDDirector
Trustee or director
1$0
Kristen R Scarpato MD MPHDirector
Trustee or director
1$0
Pam MurphyExecutive Dir.
Officer
1$0
990 for the year ended April 30, 2023: 10 people
NameTitleHours / weekCompensation
VIRAJ A MASTER MD PHD FACSPresident
Trustee or director, Officer
1$0
BRIAN MATTHEW SHUCH MDTreasurer
Trustee or director, Officer
1$0
GENNADY BRATSLAVSKY MDPAST PRESIDENT
Trustee or director, Officer
1$0
Jeffrey Maxwell HolzbeierleinDirector
Trustee or director
1$0
Daniel W Lin MDDirector
Trustee or director
1$0
Adam Stuart Kibel MDDirector
Trustee or director
1$0
SAM S CHANG MD MBADirector
Trustee or director
1$0
W Marston Linehan MDDirector
Trustee or director
1$0
KRISTEN R SCARPATO MD MPHDirector
Trustee or director
1$0
Pam MurphyExecutive Dir.
Officer
1$0

Address and contacts

Address (IRS master file)
1933 N MEACHAM RD STE 450, SCHAUMBURG, IL 60173-4410
In care of
% JANET WARD
Principal officer (990 for 2024)
Brian Matthew Shuch MD, 1933 North Meacham Road 450, SCHAUMBURG, IL 60173
Signed the 990
Brian Matthew Shuch MD, Treasurer
Phone
(847) 517-7225
Return prepared by
IL NFP AUDIT AND TAX LLP

Mission

THE SOCIETY IS A NATIONAL ALLIANCE OF LEADING ACADEMIC AND COMMUNITY BASED URO-ONCOLOGISTS COMMITTED TO THE FOLLOWING - TO FURTHER UROLOGY RESEARCH AND PHARMACEUTICAL TRIALS, - TO OFFER & PROVIDE FOR THE BEST POSSIBLE APPROACH TO DISEASE EDUCATION AND MANAGEMENT PROVIDING FOR BETTER PATIENT OUTCOMES, - TO PROVIDE EDUCATION FOR THE PROFESSION TO FURTHER THE LEARNINGS CONDUCTED THROUGH THE PROFESSION, - AND TO ALLOW CLINICIANS TO BE AWARE OF EXISTING RESEARCH, WHICH ADVANCES FURTHER CLINICAL EDUCATION AND HYPOTHESES.

990 for the year ended April 30, 2025

Program accomplishments

  • THE CONSORTIUM ASSISTS DOCTORS AND HOSPITALS CONDUCTING CLINICAL TRIALS WITH EXPEDITED CONCEPT AND PROTOCOL REVIEW, STANDARDIZED PROTOCOL AND CONTRACT LANGUAGE, AND CENTRALIZED DATA MANAGEMENT TO HELP TEST NEEDED THERAPIES MORE RAPIDLY THE SUO-CTC DIRECTS REVENUES GENERATED FROM SPONSOR AGREEMENTS TO FUND THE COLLECTIVE ACADEMIC, RESEARCH, CORPORATE AND ADMINISTRATIVE OBJECTIVES OF THE CONSORTIUM IN RETURN THE SUO-CTC OFFERS A VARIETY OF VALUE-ADDED SERVICES WHICH ARE OF SHARED BENEFIT TO THE URO-ONCOLOGY COMMUNITY, PHARMACEUTICAL INDUSTRY BOTH LOCALLY AND ABROAD.
    Expenses $253,237 · revenue $684,500

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in April, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025April 30, 2026September 15, 2026Not on file
2024April 30, 2025September 15, 2025990 on file
2023April 30, 2024September 16, 2024990 on file

IRS record

EIN
26-2943602
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (509(a)(2))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2010
Accounting year ends
April
Files
Form 990 or 990-EZ
Category (NTEE)
Medical research (H30)
Assets (IRS master file)
$1,810,558
Income (IRS master file)
$684,500

Filing history

FormYear endedRevenueExpensesAssetsReturn
990April 2025$684,500$313,029$1,810,558XML
990April 2024$553,700$270,281$1,404,532XML
990April 2023$332,300$237,946$1,105,625XML
990April 2022$626,645$183,608$1,019,541IRS
990April 2021–––IRS
990April 2019–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 26-2943602).

Questions about SOCIETY OF UROLOGIC ONCOLOGY CLINICAL TRIALS CONSORTIUM

What is the EIN of SOCIETY OF UROLOGIC ONCOLOGY CLINICAL TRIALS CONSORTIUM?
The employer identification number (EIN) of SOCIETY OF UROLOGIC ONCOLOGY CLINICAL TRIALS CONSORTIUM is 26-2943602.
Is SOCIETY OF UROLOGIC ONCOLOGY CLINICAL TRIALS CONSORTIUM tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2010.
Are donations to SOCIETY OF UROLOGIC ONCOLOGY CLINICAL TRIALS CONSORTIUM tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does SOCIETY OF UROLOGIC ONCOLOGY CLINICAL TRIALS CONSORTIUM file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of SOCIETY OF UROLOGIC ONCOLOGY CLINICAL TRIALS CONSORTIUM due?
The return for tax year 2025 (the year ending April 30, 2026) is due September 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did SOCIETY OF UROLOGIC ONCOLOGY CLINICAL TRIALS CONSORTIUM last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended April 2025.
Who is the principal officer of SOCIETY OF UROLOGIC ONCOLOGY CLINICAL TRIALS CONSORTIUM?
The 990 for the year ended April 30, 2025 names Brian Matthew Shuch MD.
Who are the officers and directors of SOCIETY OF UROLOGIC ONCOLOGY CLINICAL TRIALS CONSORTIUM?
The 990 for the year ended April 30, 2025 lists 10 people; 0 received compensation from the organization.
How much revenue does SOCIETY OF UROLOGIC ONCOLOGY CLINICAL TRIALS CONSORTIUM have?
On its 990 for the year ended April 30, 2025 it reported revenue of $684,500, expenses of $313,029 and total assets of $1,810,558 at year end.

Other nonprofits in SCHAUMBURG

All nonprofits in SCHAUMBURG · Illinois · Medical research